CeRNA network reveals potential diagnostic biomarkers or immunotherapy targets for Hypopharyngeal squamous cell carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identified NRG1, CCNG2, and CHSY1 as key diagnostic biomarkers for Head and Neck Squamous Cell Carcinoma (HSCC). These biomarkers form a ceRNA network, offering new insights for HSCC screening and treatment.
Area Of Science
- Oncology
- Bioinformatics
- Molecular Biology
Background
- Head and Neck Squamous Cell Carcinoma (HSCC) requires novel diagnostic biomarkers.
- Understanding the competing endogenous RNA (ceRNA) regulatory network is crucial for HSCC research.
Purpose Of The Study
- To construct a ceRNA network for HSCC.
- To identify potential diagnostic and prognostic biomarkers for HSCC.
Main Methods
- Bioinformatic analysis of differentially expressed RNAs (circRNAs, mRNAs, miRNAs) in HSCC.
- Univariate Cox analysis and survival curve analysis to identify prognostic biomarkers.
- Construction of a ceRNA network and validation using qRT-PCR.
Main Results
- A comprehensive ceRNA network involving 90 miRNAs, 47 circRNAs, and 111 mRNAs was constructed.
- NRG1, CCNG2, and CHSY1 were identified as significant prognostic and diagnostic biomarkers for HSCC with excellent diagnostic value (AUC > 0.9).
- Expression patterns of NRG1 and CHSY1 were validated in clinical samples, confirming their association with HSCC malignancy and immunotherapy response.
Conclusions
- NRG1, CCNG2, and CHSY1 are promising diagnostic biomarkers for HSCC.
- The established ceRNA network provides a foundation for understanding HSCC pathogenesis.
- This study offers novel insights for the clinical screening and therapeutic strategies for HSCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.